URGCP increases the recruitment of NF-κB transcription factors to the promoter region of MMP-9, and the inhibition of NF-κB activity through an IκBα mutant decreases MMP-9 expression and the invasive ability of URGCP-overexpressing NSCLC cells. Here, MMP9 is linked to non-small cell lung carcinoma.